Citizens analyst Jonathan Wolleben downgraded Kalvista Pharmaceuticals Inc (NASDAQ: KALV) from Market Outperform to Market Perform.

For an analyst ratings summary and ratings history on Kalvista Pharmaceuticals Inc click here. For more ratings news on Kalvista Pharmaceuticals Inc click here.

Shares of Kalvista Pharmaceuticals Inc closed at $19.24 yesterday.